Beijing Aosaikang Pharmaceutical Co., Ltd. (SHE:002755)
16.21
+0.96 (6.30%)
Apr 29, 2026, 3:04 PM CST
SHE:002755 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 1,284 | 1,422 | 1,411 | 1,047 | 772.71 | 1,166 |
Trading Asset Securities | 1,197 | 1,059 | 683.28 | 713.83 | 839.08 | 522.39 |
Cash & Short-Term Investments | 2,481 | 2,481 | 2,095 | 1,761 | 1,612 | 1,688 |
Cash Growth | 8.71% | 18.43% | 18.96% | 9.25% | -4.51% | 14.90% |
Accounts Receivable | 201.65 | 279.17 | 231.83 | 181.24 | 323.03 | 581.86 |
Other Receivables | 6.66 | 6.77 | 13.02 | 49.88 | 25.21 | 16.29 |
Receivables | 208.31 | 285.94 | 244.85 | 231.12 | 348.23 | 598.15 |
Inventory | 117.69 | 124.55 | 196.99 | 167.49 | 141.53 | 141.84 |
Other Current Assets | 114.68 | 99.24 | 31.59 | 27 | 36.56 | 59.14 |
Total Current Assets | 2,921 | 2,991 | 2,568 | 2,186 | 2,138 | 2,487 |
Property, Plant & Equipment | 407.46 | 415.06 | 474.03 | 478.4 | 547.14 | 658.33 |
Long-Term Investments | 47.1 | 47.61 | 118.72 | 118.21 | 107.57 | 105.18 |
Other Intangible Assets | 562.28 | 578.89 | 146.34 | 98.34 | 95.77 | 97.69 |
Long-Term Deferred Tax Assets | 24.65 | 24.65 | 24.62 | 25.73 | 25.85 | 28.69 |
Long-Term Deferred Charges | 524.5 | 423.1 | 676.78 | 563.46 | 453.7 | 342.02 |
Other Long-Term Assets | 36.01 | 37.26 | 38.97 | 53.26 | 46.22 | 5.75 |
Total Assets | 4,523 | 4,517 | 4,048 | 3,524 | 3,414 | 3,725 |
Accounts Payable | 47.32 | 121.07 | 59.98 | 38.29 | 39.08 | 65.72 |
Accrued Expenses | 7.56 | 26.75 | 40.84 | 43.6 | 119.56 | 133.48 |
Short-Term Debt | - | 27 | 62 | 114.02 | 45.03 | - |
Current Portion of Long-Term Debt | 2.88 | 2.79 | - | - | - | - |
Current Portion of Leases | - | - | 4.06 | 3.03 | 3.45 | 2.61 |
Current Income Taxes Payable | 36.8 | 42.06 | 2.05 | 3.59 | 2.13 | 7.54 |
Current Unearned Revenue | 237.97 | 282 | 108.51 | 15.88 | 11.68 | 15.26 |
Other Current Liabilities | 736.63 | 665.16 | 543.53 | 213.14 | 102.81 | 177.11 |
Total Current Liabilities | 1,069 | 1,167 | 820.96 | 431.55 | 323.74 | 401.71 |
Long-Term Leases | 3.43 | 4.04 | 6.62 | 6.75 | 8.92 | 11.52 |
Long-Term Unearned Revenue | 54.99 | 56.1 | 60.66 | 64.72 | 55.81 | 68.93 |
Long-Term Deferred Tax Liabilities | 16.01 | 16.01 | 17.15 | 10.18 | 12.56 | 15.08 |
Total Liabilities | 1,144 | 1,243 | 905.39 | 513.2 | 401.03 | 497.24 |
Common Stock | 928.16 | 928.16 | 928.16 | 928.16 | 928.16 | 928.16 |
Additional Paid-In Capital | 163.64 | 163.64 | 136.94 | 136.94 | 50.73 | 0.94 |
Retained Earnings | 2,198 | 2,114 | 1,989 | 1,828 | 1,977 | 2,295 |
Comprehensive Income & Other | 10.82 | 9.78 | 8.95 | 6.58 | 7.25 | -5.9 |
Total Common Equity | 3,301 | 3,215 | 3,063 | 2,900 | 2,963 | 3,219 |
Minority Interest | 78.73 | 58.71 | 79.59 | 110.7 | 50.37 | 8.82 |
Shareholders' Equity | 3,380 | 3,274 | 3,142 | 3,011 | 3,013 | 3,228 |
Total Liabilities & Equity | 4,523 | 4,517 | 4,048 | 3,524 | 3,414 | 3,725 |
Total Debt | 6.31 | 33.83 | 72.67 | 123.8 | 57.41 | 14.13 |
Net Cash (Debt) | 2,474 | 2,447 | 2,022 | 1,637 | 1,554 | 1,674 |
Net Cash Growth | 11.10% | 21.01% | 23.52% | 5.32% | -7.14% | 15.51% |
Net Cash Per Share | 2.60 | 2.59 | 2.14 | 1.76 | 1.65 | 1.81 |
Filing Date Shares Outstanding | 938.54 | 994.19 | 928.16 | 928.16 | 928.16 | 928.16 |
Total Common Shares Outstanding | 938.54 | 994.19 | 928.16 | 928.16 | 928.16 | 928.16 |
Working Capital | 1,852 | 1,824 | 1,747 | 1,755 | 1,814 | 2,085 |
Book Value Per Share | 3.52 | 3.23 | 3.30 | 3.12 | 3.19 | 3.47 |
Tangible Book Value | 2,739 | 2,637 | 2,916 | 2,802 | 2,867 | 3,121 |
Tangible Book Value Per Share | 2.92 | 2.65 | 3.14 | 3.02 | 3.09 | 3.36 |
Buildings | - | - | 385.96 | 375.5 | 371.29 | 437.94 |
Machinery | - | - | 804.36 | 744.21 | 767.2 | 776.51 |
Construction In Progress | - | - | 23.51 | 36.07 | 29.8 | 19.71 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.